Kenji Tago

Prof. Kenji Tago

Division of Structural Biochemistry, Department of Biochemistry, School of Medicine, Jichi Medical University, 3311‐1 Yakushiji, Shimotsuke‐shi, Tochigi 329‐0498, Japan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2018 in Science Advances
Verified
Journal Article
Open access
PDF file
YMYuki Miyamoto
Yuki Miyamoto
TTTomohiro Torii
Tomohiro Torii
Kenji TagoKenji Tago
Kenji Tago
ATAkito Tanoue
Akito Tanoue
STShou Takashima
Shou Takashima
Junji YamauchiJunji Yamauchi
Junji Yamauchi
BIG1 and its effector Arf1 are newly added to the list of signaling molecules controlling axonal myelination.

3 October 2019 in Molecular Oncology
Verified
Journal Article
Open access
PDF file
Kenji TagoKenji Tago
Kenji Tago
MFMegumi Funakoshi-Tago
Megumi Funakoshi-Tago
SOSatoshi Ohta
Satoshi Ohta
HKHirotoshi Kawata
Hirotoshi Kawata
HSHiroshi Saitoh
Hiroshi Saitoh
KYKen Yanagisawa
Ken Yanagisawa
It is well established that nuclear factor κB (NF‐κB) acts as one of the most important transcription factors for tumor initiation and progression, as it both protects cells from apoptotic/necrotic signals and accelerates angiogenesis and tumor metastasis, which is mediated via the expression of target genes. However, it has not yet been clarified how oncogenic signals accelerate the activation of NF‐κB. In the current study, we utilized untransformed NIH‐3T3 cells stably harboring a κB‐driven luciferase gene to show that an oncogenic mutant of Ras GTPase augmented TNFα‐induced NF‐κB activation. Notably, enforced expression of cyclin‐dependent kinase inhibitors, such as p27Kip1 and p21Cip1, effectively canceled the accelerated activation of NF‐κB, suggesting that oncogenic Ras‐induced cell cycle progression is essential for the hyperactivation of NF‐κB. Furthermore, we found that Ras (G12V) augmented the transcriptional activation of NF‐κB, and this activation required the p38 MAP kinase. We observed that a downstream kinase of p38 MAP kinase, MSK1, was activated by Ras (G12V) and catalyzed the phosphorylation of p65/RelA at Ser‐276, which is critical for its transcriptional activation. Significantly, phosphorylation of the p65/RelA subunit at Ser‐276 was elevated in patient samples of colorectal cancer harboring oncogenic mutations of the K‐Ras gene, and the expression levels of NF‐κB target genes were drastically enhanced in several cancer tissues. These observations strongly suggest that oncogenic signal‐induced acceleration of NF‐κB activation is caused by activation of the p38 MAP kinase–MSK1 signaling axis and by cell cycle progression in cancer cells.

3 January 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MFMegumi Funakoshi-Tago
Megumi Funakoshi-Tago
KSKazuya Sumi
Kazuya Sumi
TKTadashi Kasahara
Tadashi Kasahara
Kenji TagoKenji Tago
Kenji Tago
The acquired mutation (V617F) of Janus kinase 2 (JAK2) is observed in the majority of patients with myeloproliferative neoplasms (MPNs). In the screening of genes whose expression was induced by JAK2 (V617F), we found the significant induction of c-Myc mRNA expression mediated by STAT5 activation. Interestingly, GSK-3β was inactivated in transformed Ba/F3 cells by JAK2 (V617F), and this enhanced the protein expression of c-Myc. The enforced expression of c-Myc accelerated cell proliferation but failed to inhibit apoptotic cell death caused by growth factor deprivation; however, the inhibition of GSK-3β completely inhibited the apoptosis of cells expressing c-Myc. Strikingly, c-Myc T58A mutant exhibited higher proliferative activity in a growth-factor-independent manner; however, this mutant failed to induce apoptosis. In addition, knockdown of c-Myc significantly inhibited the proliferation of transformed cells by JAK2 (V617F), suggesting that c-Myc plays an important role in oncogenic activity of JAK2 (V617F). Furthermore, JAK2 (V617F) induced the expression of a target gene of c-Myc, ornithine decarboxylase (ODC), known as the rate-limiting enzyme in polyamine biosynthesis. An ODC inhibitor, difluoromethylornithine (DFMO), prevented the proliferation of transformed cells by JAK2 (V617F). Importantly, administration of DFMO effectively delayed tumor formation in nude mice inoculated with transformed cells by JAK2 (V617F), resulting in prolonged survival; therefore, ODC expression through c-Myc is a critical step for JAK2 (V617F)-induced transformation and DFMO could be used as effective therapy for MPNs.

27 September 2023 in Neurochemistry International
Verified
Journal Article
Closed access
TMTaisuke Murata
Taisuke Murata
SISho Ishiwa
Sho Ishiwa
XLXin Lin
Xin Lin
YNYosuke Nakazawa
Yosuke Nakazawa
Kenji TagoKenji Tago
Kenji Tago
MFMegumi Funakoshi-Tago
Megumi Funakoshi-Tago

1 July 2021 in ImmunoHorizons
Verified
Journal Article
Open access
PDF file
FAFumiya Anzai
Fumiya Anzai
TKTadayoshi Karasawa
Tadayoshi Karasawa
TKTakanori Komada
Takanori Komada
NYNaoya Yamada
Naoya Yamada
YMYutaka Miura
Yutaka Miura
MTMasafumi Takahashi
Masafumi Takahashi
Calciprotein particles (CPPs) are nanoparticles composed of calcium phosphate crystals and fetuin-A and have been implicated in diseases associated with inflammation. In the current study, we investigated the molecular mechanisms underlying CPP-induced inflammation in mice. CPPs predominantly upregulated IL-1β and IL-1α and provided priming and activation signals for the NLRP3 inflammasome in murine macrophages. Pharmacological and genetic inhibition of the NLRP3 inflammasome revealed that CPPs induced the release of IL-1β and IL-1α via NLRP3 inflammasome-dependent and -independent mechanisms, respectively. CPPs also induced necrotic cell death, but gasdermin D was dispensable for CPP-induced IL-1β release and necrotic cell death. Although phagocytosis of CPPs was required for CPP-induced IL-1β/α release and necrotic cell death, lysosomal dysfunction and K+ efflux were mainly involved in CPP-induced NLRP3 inflammasome activation and subsequent IL-1β release but not in CPP-induced IL-1α release and necrotic cell death. In vivo experiments showed that CPP administration evoked acute inflammatory responses characterized by neutrophil accumulation via both IL-1β and IL-1α. In particular, CPP-induced neutrophil inflammation was mediated predominantly through an IL-1α–induced CXCL1/CXCR2 signaling pathway. These results provide new insights into the mechanism underlying CPP-induced inflammation and suggest that targeting both IL-1β and IL-1α is necessary to regulate the CPP-induced inflammatory response and to treat CPP-associated inflammatory disorders.

1 November 2021 in International Immunopharmacology
Verified
Journal Article
Closed access
XLXin Lin
Xin Lin
Kenji TagoKenji Tago
Kenji Tago
NONozomi Okazaki
Nozomi Okazaki
TSTakanori So
Takanori So
KTKyoko Takahashi
Kyoko Takahashi
MFMegumi Funakoshi-Tago
Megumi Funakoshi-Tago